
1. bmc infect dis. 2012 nov 15;12:307. doi: 10.1186/1471-2334-12-307.

in vitro antimalarial susceptibility molecular markers drug resistance 
franceville, gabon.

zatra r(1), lekana-douki jb, lekoulou f, bisvigou u, ngoungou eb, ndouo fs.

author information: 
(1)unité de parasitologie médicale (uparam), centre international de recherches
médicales de franceville (cirmf), franceville, gabon.

background: malaria remains major public health problem, due largely to
emergence widespread p. falciparum drug resistance. recommends
artemisinine combination based therapy (act) overcome p. falciparum drug
resistance, reports declining act efficacy published. thorough
understanding molecular bases p. falciparum resistance existing
drugs therefore needed. aims study analyze vitro
sensitivity p. falciparum field isolates franceville, gabon, to
chloroquine (cq), mefloquine (mf), dihydroartemisinine (dha) and
monodesethylamodiaquine (mdaq), investigate polymorphisms associated 
drug resistance.
methods: conducted cross-sectional study 53 field isolates. field
isolates sensitivity cq, mf, dha mdaq assessed using colorimetric 
deli test. pfmdr1 codons 86 1246, pfcrt (haplotype codon 72 76) and
the pfatpase6 codons 110 2694 analysed pcr-rflp. associations between
drug sensitivity parasite gene polymorphisms evaluated chi
square test, routine hematological parameters analyzed fisher's
exact test implemented epinfo software. statistical tests,
significance assumed p<0.05.
results: total 46 p. falciparum isolates successfully cultured vitro
and sensitivity tested. proportions isolates resistant cq, mf
and mdaq 43.5%, 23.4% 56.5%, respectively. isolates (23.9%) dha
ic50 values higher 10 nm. median ic50 values 71.67 (interquartile
range (iqr, 1-438.2), 6.59 (iqr, 0.08-96), 64.79 (iqr, 0.09-448) 6.45 nm
(iqr, 0.09-23) cq, mf, mdaq dha, respectively. strongest correlation 
between diminished dha sensitivity mf resistance observed (r2=0.73),
followed correlation diminished dha sensitivity cq resistance.
cross-resistance cq mf also observed. prevalence 86y
and 1246y mutations pfmdr1, 76t pfcrt, 110a 2694t pfatpase6 
respectively 42% 17.1%, 97.8%, 0% 22.2%.
conclusion: high levels antimalarial drug resistance franceville,
gabon, call reinforced surveillance drug efficacy.

doi: 10.1186/1471-2334-12-307 
pmcid: pmc3534593
pmid: 23153201  [indexed medline]

